Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present a corporate overview at the 39 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13 th at 5:20pm EST.
The virtual session will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations . The presentation will also be available on the Sangamo website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation. For more information about Sangamo, visit www.sangamo.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210105005148/en/
Investor Relations & Media Inquiries
Aron Feingold
628.252.7494
afeingold@sangamo.com